Paramount Skydance Corp
PSKYSync financial data to generate a health grade for this company.
Analytical Summary
On an absolute basis, Paramount Skydance Corp shows solid but mixed fundamentals. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.
9-Year Financial Trajectory
Quarterlyinfo Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.
Dividend History
Dividend / share · sourced from SEC filingsStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Revenue Growth YoY (%) | — | — |
-61.7%
Weak
Weak
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Below avg (-871%)
|
— | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin (%) (%) |
8.4%
Caution
Caution
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-58%)
|
— |
3.1%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-85%)
|
— | — |
1.6%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-92%)
|
5.0%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-75%)
|
— | — |
| Profit Margin (%) (%) |
2.3%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-85%)
|
— |
-9.5%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-163%)
|
— | — |
-2.8%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-119%)
|
0.0%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-100%)
|
— | — |
| FCF Margin (%) (%) |
1.3%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— |
8.6%
Caution
Caution
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — |
0.7%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — | — |
| FCF / Net Income (x) |
0.57x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
-0.91x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
-0.25x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Return on Invested Capital (%) |
4.2%
Caution
Caution
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— |
0.5%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
0.6%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — | — |
| Return on Capital (%) (%) |
1.4%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— |
0.2%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — |
0.3%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — |
| Return on Common Equity (%) (%) |
1.4%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-88%)
|
— |
-2.0%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-117%)
|
— | — |
-1.4%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-111%)
|
— | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Interest Coverage (x) |
2.37x
Caution
Caution
Operating income divided by interest expense
Optimal:
> 5x
|
— |
0.54x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— | — |
0.82x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— | — | — |
| Net Debt (USD) | $-1.94B | $-3.27B | $-3.26B | — | — | $-2.66B | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $1.05B | $2.72B | $3.32B | $0.00 | $0.00 | $2.91B | — | — | — |
| Total Equity (USD) | $11.71B | $11.69B | $12.01B | $0.00 | $0.00 | $16.32B | — | $0.00 | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $7.35B | — | $2.58B | $0.00 | $0.00 | $7.98B | $6.73B | $0.00 | — |
| Net Income, GAAP (USD) | $168.00M | — | $-244.00M | $0.00 | $0.00 | $-224.00M | $1.00M | $0.00 | — |
| Operating Cash Flow (USD) | $185.00M | — | $268.00M | $-180.00M | $0.00 | $168.00M | — | $0.00 | — |
Secondary lens
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Unavailable
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Benchmarks unavailable
Verdicts use absolute quality thresholds, not peer comparison — only 0 comparable companies are currently available for ranking.
Use Statement Evidence firstCompare PSKY with peers
Stack PSKY against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 3 years · 9 quarters